Our vision is to develop new treatments for children with cardiotoxic heart damage and cardiomyopathies.

The Heart Disease Team aims to develop new therapies for children with cardiotoxic heart damage and cardiomyopathies using stem cell technologies.

Our laboratory utilises pluripotent stem cells to create human models of disease as a platform for therapeutic development.

Our research pipeline spans the full spectrum from the clinic to the single cell, taking full advantage of the unique capacity of the multidisciplinary team at the Melbourne Children’s campus.

The Team are generating heart organoids from patient stem cells, which can be used to investigate genetic causes of childhood heart disease in patients, as well as to screen for drugs that damage or regenerate heart tissue.

More information